-
Weaver and colleagues at Intermountain Medical Center in Murray, Utah, conducted a prospective study to determine the false-positive rate of carboxyhemoglobin (COHb) measurements by pulse oximetry (SpCO) in patients presenting to the emergency department at this level one trauma center.
-
Lu et al prospectively studied 165 patients with culture-confirmed (bronchoalveolar lavage samples), ventilator-associated pneumonia (VAP) caused by either Pseudomonas aeruginosa or Acinetobacter baumannii.
-
Hampson and colleagues present a review of the literature and pathophysiology of carbon monoxide (CO) poisoning and provide treatment and prevention recommendations.
-
The modern-day intensive care unit (ICU) is a cacophony of noise from beeps, buzzers, loud conversations, and harsh lighting. Stimuli overload has been documented to be detrimental to critically ill patients.
-
Bacteria were present on the cell phones of all hospital clinicians studied, with potentially pathogenic microorganisms isolated from 29% of them. Contamination with pathogens was found more commonly with smart phones than with non-smart phones, and by multivariable analysis no other factor was associated with this difference.
-
-
This study reports a correlation between the degree of abnormalities on high-resolution chest CT and both restrictive pulmonary dysfunction and poorer health-related quality of life among survivors of acute lung injury.
-
Chronically critically ill patients who receive care in either acute care ICUs or in long-term acute care hospitals have similar 1-year survival rates. However, long-term acute care hospitals incur a higher overall cost, due to higher Medicare reimbursement rates to these facilities.
-
A recruitment maneuver (RM) is the technique of briefly increasing alveolar pressure to levels in excess of what normally is recommended to reopen collapsed peripheral airways and alveoli so that both resting lung volume, or functional residual capacity (FRC), and oxygenation are restored.1
-
Chelation therapy for cardiovascular disease; statins and kidney injuries; chlorthalidone for hypertension; and FDA actions.
